Holen Sie sich die Stockscreener-App
278.66
0.47%
-1.3328
Schlusskurs vom Vortag:
$279.99
Offen:
$279.57
24-Stunden-Volumen:
125.83K
Relative Volume:
0.45
Marktkapitalisierung:
$7.52B
Einnahmen:
$2.58B
Nettoeinkommen (Verlust:
$759.90M
KGV:
9.9817
EPS:
27.9168
Netto-Cashflow:
$374.60M
1W Leistung:
+3.08%
1M Leistung:
+3.27%
6M Leistung:
-9.86%
1J Leistung:
+23.53%
1-Tages-Spanne:
$276.32
$280.78
1-Wochen-Bereich:
$270.85
$284.45
52-Wochen-Spanne:
$211.43
$343.12
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Firmenname
Bio Rad Laboratories Inc
Sektor
Branche
Telefon
(510) 724-7000
Adresse
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
278.78 | 7.56B | 2.58B | 759.90M | 374.60M | 27.92 |
ABT
Abbott Laboratories
|
102.16 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
332.10 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.25 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.55 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.03 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-06-16 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-01-28 | Bestätigt | Citigroup | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2018-10-17 | Eingeleitet | Goldman | Buy |
| 2018-09-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Herabstufung | CL King | Buy → Neutral |
| 2017-07-13 | Eingeleitet | Wells Fargo | Outperform |
| 2017-06-28 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Hold |
| 2016-10-13 | Eingeleitet | CL King | Buy |
| 2015-05-06 | Bestätigt | Jefferies | Buy |
| 2009-12-18 | Eingeleitet | Maxim Group | Buy |
| 2009-11-06 | Eingeleitet | Jefferies & Co | Buy |
| 2009-07-17 | Eingeleitet | Soleil | Buy |
| 2007-09-26 | Eingeleitet | Banc of America Sec | Buy |
| 2007-02-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
DNA/RNA Extraction Kit Market to Reach US$6.78 Billion by 2033 - openPR.com
Protein Chip Market to Reach US$4.8 Billion by 2033 at 7.5% CAGR; - openPR.com
BIO Technical Analysis & Stock Price Forecast - Intellectia AI
BIO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Bio-Rad Laboratories, Inc. (BIO) Stock forecasts - Yahoo Finance UK
Single-cell Omics Market Is Going to Boom Rapidly |Bio-Rad - openPR.com
Shigella Test Kit Market Set to Boom Rapidly, Witnessing Strong - openPR.com
Outlook on the PCR and Realtime PCR Testing Market: Major - openPR.com
Allspring Global Investments Holdings LLC Decreases Stake in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Drug Screening Market Trends 2026–2031: Chromatography and Mass Spectrometry Held a 44.77% Share in 2025 Amid Growing Demand for Advanced Testing, Reports Mordor Intelligence - GlobeNewswire Inc.
BIO.B Should I Buy - intellectia.ai
Bio-Rad Laboratories Stock: Life Sciences Leader Faces Earnings Challenges Amid Strong Balance Sheet - AD HOC NEWS
Artisan Mid Cap Value Fund Sold Bio-Rad Laboratories (BIO) in Q4 - Insider Monkey
Molecular Quality Controls Market Set to Surge as Precision - openPR.com
SG Americas Securities LLC Buys 12,544 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Up 3.6%Time to Buy? - MarketBeat
BIO SEC FilingsBio Rad Labs Inc 10-K, 10-Q, 8-K Forms - Stock Titan
US Polymerase Chain Reaction Market Set to Boom Rapidly, - openPR.com
Wellness and Longevity Diagnostics Market Hits New High | Major - openPR.com
U.S. Magnetic Beads Market is Booming with Strong Growth - openPR.com
Calorimetric Biosensor Market Is Going to Boom | PerkinElmer Inc. • Bio-Rad Laboratories Inc - openPR.com
Malaria Diagnostics Market Projected To Witness Massive - openPR.com
Real Time PCR and Digital PCR Market Set to Boom Rapidly by 2033| - openpr.com
Exchange Traded Concepts LLC Has $8.97 Million Stock Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories Stock: A Cornerstone in Life Sciences Tools Amid Precision Medicine Momentum - AD HOC NEWS
Is Bio Rad Laboratories Inc a cyclical or defensive stockWeekly Trade Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Stock List: Research Stocks from Around the World - gurufocus.com
Electrophoresis Reagents Market Expands with North America - openPR.com
Vanguard disaggregates holdings; Bio‑Rad Labs (NYSE: BIO) shows 0 shares - Stock Titan
Bio-Rad Laboratories Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo
Executive pay, equity plan and dual-class vote at Bio-Rad (NYSE: BIO) 2026 meeting - Stock Titan
[ARS] BIO-RAD LABORATORIES, INC. SEC Filing - Stock Titan
Biosensors Market Is Going to BoomKey Factors Driving - openPR.com
Enzyme Linked Immunosorbent Assay Market Future Business - openPR.com
BIO Technical Analysis | Trend, Signals & Chart Patterns | BIO-RAD LABORATORIES-A (NYSE:BIO) - ChartMill
Retail Trends: What is the long term forecast for Bio Rad Laboratories Inc. stock2026 Breakouts & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Bio-Rad Laboratories Experiences Evaluation Revision Amid Mixed Market Signals and Performance Trends - Markets Mojo
Disappointing Results Hurt Bio-Rad Laboratories (BIO) - Insider Monkey
Moving Averages: Is Bio Rad Laboratories Inc likely to announce a buybackWeekly Trend Summary & Breakout Confirmation Alerts - baoquankhu1.vn
Capillary Electrophoresis Market size to hit $632.8 Million - openPR.com
Bio-Rad Laboratories Inc (BIO) Stock Price Up 3.06% on Mar 17 - gurufocus.com
Discipline and Rules-Based Execution in BIO Response - news.stocktradersdaily.com
Moore Capital Management LP Acquires Shares of 55,000 Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Gotham Asset Management LLC Acquires 36,763 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Hound Partners LLC Has $29.15 Million Stake in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Mangrove Partners IM LLC Invests $35.57 Million in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Perbak Capital Partners LLP Purchases 5,423 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Portolan Capital Management LLC Has $13.02 Million Stock Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
10,425 Shares in Bio-Rad Laboratories, Inc. $BIO Purchased by Magnetar Financial LLC - MarketBeat
Bio-Rad Laboratories, Inc. $BIO Shares Purchased by Natixis Advisors LLC - MarketBeat
Finanzdaten der Bio Rad Laboratories Inc-Aktie (BIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.25%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):